Breast Cancer Clinical Trials in High Point, NC

Breast Cancer Clinical Trials in High Point, NC

View the best 10 breast cancer medical studies in High Point, North Carolina. Access promising new therapies by applying to a High Point-based Breast Cancer clinical trial.

Trials in High Point, North Carolina

Here are the top 10 medical studies for breast cancer in High Point, North Carolina

Image of University of Alabama at Birmingham in Birmingham, United States.

Gedatolisib +2 More

PI3K/mTOR Inhibitor

Recruiting2 awardsPhase 3
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Image of Beverly Hills Cancer Center in Beverly Hills, United States.

Inavolisib +2 More

PI3K Inhibitor

Recruiting0 awardsPhase 2 & 3
This trial tests a new drug combination (inavolisib, palbociclib, and fulvestrant) for patients with a specific type of advanced breast cancer that got worse after hormone therapy. The treatment aims to stop cancer cells from growing and spreading by attacking them in different ways.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Paclitaxel

Anti-mitotic Agent

Recruiting1 awardPhase 2
This trial is testing radium-223 dichloride (a radioactive drug) + paclitaxel (a chemotherapy drug) to see if it's more effective than paclitaxel alone in treating patients with metastatic breast cancer.
Image of Indiana University Melvin and Bren Simon Comprehensive Cancer Center in Indianapolis, United States.

Talazoparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether different targeted therapies can improve outcomes for women with residual Triple Negative Breast Cancer after pre-operative treatment.
Image of Research Site in Farmington, United States.

Camizestrant

Selective Estrogen Receptor Degrader (SERD)

Recruiting2 awardsPhase 3
This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.
Image of Banner MD Anderson Cancer Center in Gilbert, United States.

LY3484356

Immunotherapy

Recruiting1 awardPhase 1
This trial will test if a new drug is safe and effective for treating people with advanced breast or endometrial cancer.
Image of University of South Alabama - Mitchell Cancer Institute in Mobile, United States.

T-DM1 +1 More

Antibody Drug Conjugate

Recruiting1 awardPhase 3
This trial is being done to see if adding tucatinib to T-DM1 helps patients with HER2 positive breast carcinoma.
Image of Mayo Clinic in Phoenix, United States.

GEN1046

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, GEN1046, to see if it is safe to use alone or with other drugs to treat cancer.
Image of University of Alabama at Birmingham in Birmingham, United States.

Stereotactic Radiosurgery +1 More

Radiation

Recruiting1 awardPhase 1 & 2
This trial is testing a combination of focused radiation, olaparib, and immunotherapy for patients with specific types of breast cancer that have spread to the brain. The treatment aims to kill cancer cells, make them more vulnerable, and boost the body's immune response. Olaparib has shown promising results in various cancers.
Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

PC14586 +1 More

Small Molecule

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.